Propanc Biopharma, Inc.
PPCB
$1.87
-$0.08-4.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 719.35% | -79.64% | 40.91% | 111.00% | -93.35% |
| Total Receivables | -32.08% | -48.72% | 26.92% | 3.45% | 60.61% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 691,350.00% | -88.43% | -55.88% | -77.05% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 75,373.64% | -91.46% | -85.25% | 33.68% | -86.65% |
|
|
|||||
| Total Current Assets | 75,373.64% | -91.46% | -85.25% | 33.68% | -86.65% |
| Net Property, Plant & Equipment | -92.44% | -77.24% | -60.43% | -54.71% | -50.22% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 639,380.00% | 2,600.00% | 1,436.84% | 1,355.00% | 0.00% |
| Total Assets | 60,295.17% | -67.55% | -64.75% | 20.07% | -74.04% |
|
|
|||||
| Total Accounts Payable | -5.55% | 5.67% | 14.55% | 25.51% | 29.35% |
| Total Accrued Expenses | 28.42% | 19.22% | 33.54% | 25.92% | 10.23% |
| Short-term Debt | 33.71% | 17.61% | 60.08% | 72.30% | 35.69% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -91.48% | -68.12% | -33.02% | -9.77% | 5.19% |
| Total Finance Division Other Current Liabilities | 21.86% | -36.18% | 11.78% | -63.87% | -3.02% |
| Total Other Current Liabilities | 21.86% | -36.18% | 11.78% | -63.87% | -3.02% |
| Total Current Liabilities | 17.71% | 10.44% | 30.90% | 20.09% | 20.51% |
|
|
|||||
| Total Current Liabilities | 17.71% | 10.44% | 30.90% | 20.09% | 20.51% |
| Long-Term Debt | 100.21% | 133.81% | 201.28% | -- | -- |
| Short-term Debt | 33.71% | 17.61% | 60.08% | 72.30% | 35.69% |
| Capital Leases | -- | -- | -- | -- | -92.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.68% | 11.35% | 31.62% | 21.21% | 21.12% |
|
|
|||||
| Common Stock & APIC | 125.31% | 1.35% | 1.57% | 2.28% | 2.78% |
| Retained Earnings | -83.22% | -2.56% | -2.88% | -3.11% | -3.85% |
| Treasury Stock & Other | 9.68% | 22.62% | -14.97% | -2.03% | 3.66% |
| Total Common Equity | 589.05% | -16.70% | -37.43% | -21.23% | -25.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 589.05% | -16.70% | -37.43% | -21.23% | -25.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 589.05% | -16.70% | -37.43% | -21.23% | -25.77% |
|
|
|||||